Invention of antibodies to disable corona

Researchers in the United States have developed new small-sized antibodies

Researchers in the United States have developed a new small-sized antibody

Researchers at the School of Medicine (UPMC) at the University of Pittsburgh in the US state of Pennsylvania have given good news about corona prevention. They have found an antibody that can play an effective role in inactivating the coronavirus.

According to a report in the British daily The Independent, scientists have isolated the smallest biological molecule capable of completely and definitively neutralizing the SARS-Cove-2 virus. The research article was published in the journal 'Cell' last Monday.

The antibodies that the researchers found were 10 times smaller than the full antibody. Using these antibodies, researchers have been able to develop a drug called AB6, which is expected to be useful in preventing and treating the virus

According to the researchers, the drug has so far been shown to be extremely effective in preventing and treating SARS-Cov-2 infections in rats.

The drug has shown symptoms so that it does not show any side effects when applied to humans or stick to human cells.

John Millers, head of the Department of Infectious Diseases at the University of Pittsburgh and UPMC and co-author of the research article, said that AB 7 would not only be used as a therapy for Covid-19, but would also protect against SARS-Cov-2 infection. The co-author of the research article was Jiang Lei, a researcher at the University of Pittsburgh.

Researcher Millers said large-sized antibodies have been identified as tolerant as well as fighting other infectious diseases.

This has given researchers hope to find an effective treatment for Covid-19. They have worked beyond conventional thinking and researched how the drug will work.

Researchers believe that the drugs they invent could be used in alternative therapies, including inhalers or plastic punches.

According to the research article, giving AB6 at a very low dose during the test has been able to eliminate the infection up to 10 times in rats.

"The Kovid-19 epidemic poses a global challenge to humanity," said researcher Millers. But the innovative skills of medicine and people will help to overcome this challenge.

We hope that the antibodies that have been discovered will play a role in overcoming the epidemic. '